Journal of Clinical Ligand Assay logo Clinical Ligand Assay Society logo

Publisher: Clinical Ligand Assay Society

Volume 27, Number 1, Spring 2004
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Current Status of Genetic Testing for Cystic Fibrosis
pp. 5-13(9)
Authors: Kristin G. Monaghan; Gerald L. Feldman

Validation of Acute Myocardial Infarction (AMI) Cut-off Point for Troponin I on the ADVIA Centaur™ Assay
pp. 14-17(4)
Authors: M.E. Salama; Carolyn S. Feldkamp; John L. Carey; James K. McCord; Mouaz Al-Mallah

Pressure Cycling Technology and Its Application in Steroid Receptor Extraction
pp. 18-23(6)
Authors: D. Alan Kerr; Irina A. Smolenkova; Andrei S. Smolenkov; James L. Wittliff

2004 Grafton Chase Education Award
pp. 24-24(1)

CLAS Syllabus 2004 Contents
pp. 25-26(2)

Glycosylation-Independent Targeting Enhances Enzyme Delivery to Lysosomes and Decreases Storage in Mucopolysaccharidosis Type VII Mice
pp. 27-34(8)
Authors: Jonathan H. LeBowitz; Jeffrey H. Grubb; John A. Maga; Deborah H. Schmiel; Carole Vogler; William S. Sly

Enzyme Replacement Therapy for Lysosomal Storage Disorders: Successful Transition from Concept to Clinical Practice
pp. 35-39(5)
Author: William S. Sly

Advancing Role of Radiolabeled Antibodies in the Therapy of Cancer
pp. 40-55(16)
Author: David M. Goldenberg

Severe Acute Respiratory Syndrome (SARS): A Brief Overview
pp. 56-57(2)
Author: T. Mazzulli

Group B Streptococcus: A Review of Rapid Detection and Susceptibility Testing
pp. 58-60(3)
Author: Barbara Robinson-Dunn

West Nile Virus: 1999–2003
pp. 61-65(5)
Author: Michael L. Wilson

A Decrease in Genetic Diversity within the NS3 Helicase Gene from Clinical Isolates of the Hepatitis C Virus Correlates with Interferon Therapy
pp. 66-75(10)
Authors: Carol A. Holland-Staley; Douglas L. Mayers

Emerging Risk Factors and CHD Risk Stratification
pp. 76-79(4)
Author: Peter W.F. Wilson

Analytical Shortcomings of the Routine Lipid-Lipoprotein Methods Currently Used for Coronary Heart Disease Risk Stratification
pp. 80-93(14)
Author: Herbert K. Naito

NMR Measurement of LDL Particles and its Clinical Advantages
pp. 94-96(3)
Author: James D. Otvos

VAP: A Better Cholesterol Test
pp. 97-100(4)
Author: Richard B. Lanman

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A